Sihuan Pharmaceutical Holdings Group Ltd. held its annual general meeting on 6 June 2025. During the meeting, several proposals were approved. These included the adoption of the audited consolidated financial statements for the year ended 31 December 2024, the re-election of retiring directors, and the extension of authority to the directors to issue shares and manage treasury shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.